Trials / Sponsors / Destiny Pharma Plc
Destiny Pharma Plc
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal In Staphylococcal Infections, Surgical Site Infection | Phase 2 | 2019-08-29 |
| Completed | Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Staphylococcus Aureus Infection | Phase 1 / Phase 2 | 2014-09-01 |
| Completed | Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Staphylococcal Infection | Phase 4 | 2014-08-01 |